Fraud Investigation


To Post 78:

This is a board for Dendreon employees, many of whom own more shares than those people on stock boards. We can not prevent stock board people from coming here but you will be called out every time you come here posting lies.

Federal investigations do not have to be disclosed. Case in point there are multiple federal investigations going on as we speak and Dendreon did not disclose. Dendreon did partially protect themselves against civil suits arising from not disclosing investigations by the following statement in their 10k:

"Civil and criminal litigation is inherently unpredictable and outcomes can result in excessive verdicts, fines, penalties and/or injunctive relief that affect how we operate our business."

As for Rosen, he was not fired for the harassment case which I'm sure Dendreon knew about when he was hired.

You are allowed to post here obviously but please stop spreading lies. If you are happy with your investment then enjoy it. Don't come here spreading lies.
 



The completely unsubstatiated investigations proposed here would most certainly have to be disclosed. Such investigations would most certainly be "material" information and the new management would certainly need to disclose them. They would not be the targets of such investigations, so why wouldn't they disclose such. The fact that no such information was disclosed in their 10-k and none of the posters here has even provided one single piece of evidence that "Fraud" or "Federal" investigations are taking place makes this entire thread bogus :

B. THE DUTY TO DISCLOSE MATERIAL INFORMATION

The duty to disclose material information arises from: (1) the need to make a periodic filing with the SEC that contains up-to-date information (such as a periodic report, a registration statement for a securities offering, or a proxy statement); (2) a regulatory requirement to disclose certain specific events as they occur; (3) a fiduciary obligation in the context of trading in the company's securities; (23) or (4) a selective disclosure (or intended selective disclosure) to a member of the professional investment community or a shareholder that triggers an obligation to disclose to the market generally. (24) Although there is no general duty to continuously update prior communications on a subject upon the discovery or development of new material facts, the issuer acquires a duty to update when the securities laws require the filing of a periodic report, current report, proxy solicitation, or registration statement. (25) In this context, an issuer must evaluate whether it must make a disclosure to ensure that a prior communication is not materially inaccurate, incomplete, or misleading.

Similarly, when a company determines that it has a duty--or otherwise chooses--to disclose information related to material facts, it has a duty to make a complete disclosure. (26) In one action, the SEC filed a settled securities fraud action against the former Chief Financial Officer and General Counsel of FFP Marketing Company, Inc. ("FFP"), for making an incomplete disclosure about the reasons for failing to file a periodic report on time. (27) In that matter, the SEC alleged that the defendant had prepared, and caused FFP to file, notices of late filing of periodic reports on Form 12b-25 that were false and misleading because they vaguely characterized the reasons for the delays as the need to obtain "[c]ertain financial and other data." (28) While this may have been true, the SEC alleged, the company failed to disclose that the reason for the delays was that the company was investigating its own accounting. (29) Because FFP made a statement that it would delay filing its Form 10-K, it was required to disclose fully the reason for the delay, affirmatively citing its internal investigation. (30)

Likewise, while an issuer need not announce that it or its officers are involved in a criminal or regulatory investigation, or that an internal investigation has been launched into particular conduct, (31) courts generally have held that if one discloses something about an investigation, the disclosure must include all material information. For example, in In re Immucor Inc. Securities Litigation, the company issued a press release disclosing an Italian criminal investigation of improper payments, and an internal investigation into the same matter. (32) The release stated that the internal investigation had revealed one incident, that the company's President and CEO had been relieved of his responsibilities as CEO, and that the company perceived a need to strengthen the controls in its European affiliates. (33) Because the plaintiffs alleged that, in fact, the investigation concerned multiple incidents of legally dubious payments, the court held that "[t]he omission creates a distorted picture of Immucor's alleged liabilities. That is, while parts of the disclosure may have been accurate, Defendants' duty was to describe fully the nature and scope of the conduct under investigation...." (34)

Absent a delineated requirement to disclose an event as it occurs, the duty to disclose may arise only with respect to "material" information. (35) Information is rendered material when there is a substantial likelihood that its disclosure "would [be] viewed by the reasonable investor as having significantly altered the 'total mix' of information made available." (36) Although practices vary with respect to disclosure of government investigations, as a matter of law, the mere existence of a government investigation alone, arguably, is not material information. (37) Rather, it is the information that the company or the government discovers through such investigations that may be material, and therefore may need to be disclosed. (38)

Determinations of materiality require assessments of both quantitative and qualitative factors. (39) More specifically, companies and their counsel must consider the extent and nature of the acts or conduct uncovered and the position(s) of the people involved in those acts or conduct. (40) Thus, for example, an investigation that uncovers the inappropriate recognition of small amounts of revenue is not likely to be material unless that improper revenue recognition was directed by a member of senior management who acted in knowing disregard of accounting principles. (41) On the other hand, an investigation related to a company's payment of bribes that do not materially impact the company's financial statements may well be material information if the company derives substantial business from government contracts and a finding of improper payments were to result in the company being barred from participating in such contracts. (42)
 












It is very easy to figure this out. If anyone believes there is no Federal Investigation, please contact the FBI office in Seattle, ask for Special Agent in Charge of Investigating Dendreon. Onceyougetconnected, you will provide your name, contact information and will revive further instructions. Then you willknowif there is investigation or not.
 



Post 87:

Can you please list everything you think is on Dendreon's legal plate. Please list by numbers. Don't get too detailed for each item. I would just like to see a list of everything including science, regulatory, compliance, stock and investors etc. Thanks!
 






Federal and other authorities know what is in the list. Do your homework, read this and other boards, read the news, talk to former and current Dendreon employees.

Can you name some other boards?

Is that you in the other post that said you are almost out of here? Hope you continue to post here. Your posts are enlightening. If I owned a pharma company Id hire you in a second. You are knowledgable in many areas and very ethical. I appreciate your insights.
 



False Statment

"No solicitation ... shall be made by means of any proxy statement, form of proxy, notice of meeting or other communication, written or oral, containing any statement which, at the time and in the light of the circumstances under which it is made, is false or misleading with respect to any material fact, or which omits to state any material fact necessary in order to make the statements therein not false or misleading ..."

To all you civil attorneys out there:

"Our overall belief in the long-term potential for PROVENGE remains strong, and we are committed to getting PROVENGE to all patients in need. These near-term issues are surmountable. They may take some time to navigate, but we believe they are readily addressable by our commercial organizations.

Our commercial team is led by our Senior Vice President of Global Commercial Operations, Robert Rosen, whose extensive oncology experience includes the launch of several major products including Eloxatin, Herceptin, and Nexavar. Rob fills the gap in our organization that has existed for approximately six months and we are glad to have him aboard."

Gold found this to be a really good selling point after the August 3 debacle. Such a good selling point that he discussed an SVP (not even an officer position) at that August 3 earnings call. The statement about the launches that Mr. Rosen was involved with was a false statement and it was publically told to the investment community.
 



They are full of it. Even new CEO and his crew are getting orders from MG and DB on the board. MG has lied so many times to all, it's not even funny. I bit, Now he is doing is transferring his wealth to his sons and rest of his family.

RR is gone because he had lied so much as well and too many law were broken under his rule. He lasted 10 month here, that is even a record low for him. But he got one year salary, bonuse, all his RSA and options were vested, couple of millions for 10 month of criminal work. You can't do better than that, oh yes, MG and rest of the EC and board members did it to all in DNDN, patients, public and investors.
 






Well the South side of Seattle
Is the baddest part of town
And if you go down there
You better just beware
Of a man named Mitch Brown

Now Mitch more than trouble
You see he stand 'bout five foot two
All the downtown ladies call him wealthy
All the men just call him fake

And it's bad, bad, bad Mitch Brown
The baddest man in Pharma
Badder than old Ken Lay
And meaner than Bernie Madoff

Now Mitch he a liar
And he like his cheap suits
And he like to wave his phony projections
In front of everybody's nose
He got a custom Continental
He got an Eldorado too
He got a 3 inch in his pocket
He got a phony projection in his shoe

Now Friday 'bout August
Mitch had to tell the truth
And at the edge of the bar
Sat a sheriff who cuffed him
And the trouble soon began
Cause Mitch Brown learned a lesson
Bout greed and the strong arm of the law
 












I finding interesting that all the post about the NAM SM illegal activity are gone. this all relates to pap and list and promotions and sales. It must be hitting a nerve which is why its removed immediately
 






Suggest for shareholders to contact Dendreon General C.,Mr. Osborn. He has to tell them the truth, if he lies then he has lied and can be recorded.

Where is the posting that published the name and the telephone number of the federal investigator? Was it cancelled or why does it not show up here anymore?
 



There has never been a posting such as the one you described. Stop making up lies. Only thing ever posted was Seattle FBI phone number in various threads. Stop being lazy and stop lying.
 




Write your reply...